Detail akcie Masimo online

Business Summary: Masimo Corporation is a global medical technology company that develops and produces a wide range of monitoring technologies, including measurements, sensors, patient monitors, automation and connectivity solutions. The Company’s healthcare products and patient monitoring solutions generally incorporate a monitor or circuit board, proprietary single-patient use or reusable sensors, software and/or cables. It primarily sells its healthcare products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, long-term care facilities. Its measurement technologies include Measure-through Motion and Low Perfusion pulse oximetry, known as Masimo Signal Extraction Technology (SET) pulse oximetry, and advanced rainbow Pulse CO-Oximetry parameters such as noninvasive hemoglobin (SpHb), alongside many other modalities, including brain function monitoring, hemodynamic monitoring, regional oximetry, capnography and gas monitoring, and others.
Financial Summary: BRIEF: For the 26 weeks ended 28 June 2025, Masimo Corp revenues increased 9% to $742.9M. Net income before extraordinary items increased 62% to $92.1M. Revenues reflect nonhealthcare segment increase from $0K to $1.6M. Net income benefited from Research and development decrease of 17% to $63.8M (expense), Advertising Expense decrease of 54% to $4.3M (expense). Basic Earnings per Share excluding Extraordinary Items increased from $1.07 to $1.70.